299 related articles for article (PubMed ID: 15286379)
1. T-cell signaling abnormalities in human systemic lupus erythematosus.
Nambiar MP; Krishnan S; Tsokos GC
Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
[TBL] [Abstract][Full Text] [Related]
2. TCR zeta-chain abnormalities in human systemic lupus erythematosus.
Nambiar MP; Krishnan S; Warke VG; Tsokos GC
Methods Mol Med; 2004; 102():49-72. PubMed ID: 15286380
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.
Nambiar MP; Juang YT; Krishnan S; Tsokos GC
Int Rev Immunol; 2004; 23(3-4):245-63. PubMed ID: 15204087
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus.
Nambiar MP; Enyedy EJ; Fisher CU; Krishnan S; Warke VG; Gilliland WR; Oglesby RJ; Tsokos GC
Arthritis Rheum; 2002 Jan; 46(1):163-74. PubMed ID: 11817588
[TBL] [Abstract][Full Text] [Related]
6. Methods and protocols to study T cell signaling abnormalities in human systemic lupus erythematosus.
Moulton VR; Lo MS; Tsokos GC
Methods Mol Biol; 2012; 900():25-60. PubMed ID: 22933064
[TBL] [Abstract][Full Text] [Related]
7. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
Fujii Y; Fujii K; Tanaka Y
Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
[TBL] [Abstract][Full Text] [Related]
8. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.
Liossis SN; Ding XZ; Dennis GJ; Tsokos GC
J Clin Invest; 1998 Apr; 101(7):1448-57. PubMed ID: 9525988
[TBL] [Abstract][Full Text] [Related]
9. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
Wong HK; Kammer GM; Dennis G; Tsokos GC
J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
[TBL] [Abstract][Full Text] [Related]
10. Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling.
Nambiar MP; Warke VG; Fisher CU; Tsokos GC
J Cell Biochem; 2002; 85(3):459-69. PubMed ID: 11967985
[TBL] [Abstract][Full Text] [Related]
11. Altered T and B lymphocyte signaling pathways in lupus.
Peng SL
Autoimmun Rev; 2009 Jan; 8(3):179-83. PubMed ID: 18721908
[TBL] [Abstract][Full Text] [Related]
12. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.
Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA
Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus.
Takeuchi T; Tsuzaka K; Abe T
Int Rev Immunol; 2004; 23(3-4):273-91. PubMed ID: 15204089
[TBL] [Abstract][Full Text] [Related]
14. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
[TBL] [Abstract][Full Text] [Related]
15. Diminished levels of T cell receptor zeta chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus.
Brundula V; Rivas LJ; Blasini AM; París M; Salazar S; Stekman IL; Rodríguez MA
Arthritis Rheum; 1999 Sep; 42(9):1908-16. PubMed ID: 10513807
[TBL] [Abstract][Full Text] [Related]
16. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.
Kammer GM
J Clin Invest; 2005 Apr; 115(4):836-40. PubMed ID: 15841173
[TBL] [Abstract][Full Text] [Related]
17. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus.
Vassilopoulos D; Kovacs B; Tsokos GC
J Immunol; 1995 Aug; 155(4):2269-81. PubMed ID: 7636273
[TBL] [Abstract][Full Text] [Related]
18. Altered signal transduction in SLE T cells.
Tenbrock K; Juang YT; Kyttaris VC; Tsokos GC
Rheumatology (Oxford); 2007 Oct; 46(10):1525-30. PubMed ID: 17586862
[TBL] [Abstract][Full Text] [Related]
19. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.
Jin ZX; Huang CR; Dong L; Goda S; Kawanami T; Sawaki T; Sakai T; Tong XP; Masaki Y; Fukushima T; Tanaka M; Mimori T; Tojo H; Bloom ET; Okazaki T; Umehara H
Int Immunol; 2008 Nov; 20(11):1427-37. PubMed ID: 18820264
[TBL] [Abstract][Full Text] [Related]
20. T cell abnormalities in systemic lupus erythematosus.
Takeuchi T; Tsuzaka K; Abe T; Yoshimoto K; Shiraishi K; Kameda H; Amano K
Autoimmunity; 2005 Aug; 38(5):339-46. PubMed ID: 16227148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
